Selected research
Industry Research
Pharmaceutical Contract Sales Organization (CSO) Industry Research Report 2026
Market perspective
The global Pharmaceutical Contract Sales Organization (CSO) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceutical Contract Sales Organization (CSO) market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Contract Sales Organization (CSO) market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Contract Sales Organization (CSO) market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Contract Sales Organization (CSO) include China Medical System (CMS), IQVIA, PHOENIX Group, EVERSANA, Ashfield Engage (Inizio), Amplity Health, Sinco Pharma, Syneos Health and EPS Corporation, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceutical Contract Sales Organization (CSO) market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Contract Sales Organization (CSO).
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Contract Sales Organization (CSO) Market by Company
China Medical System (CMS)
IQVIA
PHOENIX Group
EVERSANA
Ashfield Engage (Inizio)
Amplity Health
Sinco Pharma
Syneos Health
EPS Corporation
Uniphar Group
CMIC Group
SciClone Pharmaceuticals
China Pioneer Pharma
Promoveo Health
CSO Pharmitalia
GTS Solution
QFR Solutions
Pharmaceutical Contract Sales Organization (CSO) Segment by Type
Personal Promotion
Non-Personal Promotion
Others
Pharmaceutical Contract Sales Organization (CSO) Segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
Pharmaceutical Contract Sales Organization (CSO) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Contract Sales Organization (CSO) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Contract Sales Organization (CSO) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Contract Sales Organization (CSO).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical Contract Sales Organization (CSO) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Personal Promotion
- Non-Personal Promotion
- Others
Applications
- Pharmaceutical Company
- Biotechnology Company
- Generic Company
- Others
Companies covered
- China Medical System (CMS)
- IQVIA
- PHOENIX Group
- EVERSANA
- Ashfield Engage (Inizio)
- Amplity Health
- Sinco Pharma
- Syneos Health
- EPS Corporation
- Uniphar Group
- CMIC Group
- SciClone Pharmaceuticals
- China Pioneer Pharma
- Promoveo Health
- CSO Pharmitalia
- GTS Solution
- QFR Solutions
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Contract Sales Organization (CSO) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Personal Promotion
- 2.2.3 Non-Personal Promotion
- 2.2.4 Others
- 2.3 Pharmaceutical Contract Sales Organization (CSO) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Company
- 2.3.3 Biotechnology Company
- 2.3.4 Generic Company
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Pharmaceutical Contract Sales Organization (CSO) Breakdown Data by Type
- 3.1 Global Pharmaceutical Contract Sales Organization (CSO) Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical Contract Sales Organization (CSO) Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Contract Sales Organization (CSO) Breakdown Data by Application
- 4.1 Global Pharmaceutical Contract Sales Organization (CSO) Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical Contract Sales Organization (CSO) Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical Contract Sales Organization (CSO) Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical Contract Sales Organization (CSO) Growth Trends by Region
- 5.2.1 Global Pharmaceutical Contract Sales Organization (CSO) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical Contract Sales Organization (CSO) Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical Contract Sales Organization (CSO) Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical Contract Sales Organization (CSO) Market Dynamics
- 5.3.1 Pharmaceutical Contract Sales Organization (CSO) Industry Trends
- 5.3.2 Pharmaceutical Contract Sales Organization (CSO) Market Drivers
- 5.3.3 Pharmaceutical Contract Sales Organization (CSO) Market Challenges
- 5.3.4 Pharmaceutical Contract Sales Organization (CSO) Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical Contract Sales Organization (CSO) Players by Revenue
- 6.1.1 Global Top Pharmaceutical Contract Sales Organization (CSO) Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical Contract Sales Organization (CSO) Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical Contract Sales Organization (CSO) Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical Contract Sales Organization (CSO) Head Office and Area Served
- 6.4 Global Pharmaceutical Contract Sales Organization (CSO) Players, Product Type & Application
- 6.5 Global Pharmaceutical Contract Sales Organization (CSO) Manufacturers Established Date
- 6.6 Global Pharmaceutical Contract Sales Organization (CSO) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical Contract Sales Organization (CSO) Market Size (2021-2032)
- 7.2 North America Pharmaceutical Contract Sales Organization (CSO) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Contract Sales Organization (CSO) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical Contract Sales Organization (CSO) Market Size (2021-2032)
- 10.2 South America Pharmaceutical Contract Sales Organization (CSO) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical Contract Sales Organization (CSO) Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 China Medical System (CMS)
- 12.1.1 China Medical System (CMS) Company Information
- 12.1.2 China Medical System (CMS) Business Overview
- 12.1.3 China Medical System (CMS) Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.1.4 China Medical System (CMS) Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.1.5 China Medical System (CMS) Recent Developments
- 12.2 IQVIA
- 12.2.1 IQVIA Company Information
- 12.2.2 IQVIA Business Overview
- 12.2.3 IQVIA Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.2.4 IQVIA Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.2.5 IQVIA Recent Developments
- 12.3 PHOENIX Group
- 12.3.1 PHOENIX Group Company Information
- 12.3.2 PHOENIX Group Business Overview
- 12.3.3 PHOENIX Group Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.3.4 PHOENIX Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.3.5 PHOENIX Group Recent Developments
- 12.4 EVERSANA
- 12.4.1 EVERSANA Company Information
- 12.4.2 EVERSANA Business Overview
- 12.4.3 EVERSANA Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.4.4 EVERSANA Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.4.5 EVERSANA Recent Developments
- 12.5 Ashfield Engage (Inizio)
- 12.5.1 Ashfield Engage (Inizio) Company Information
- 12.5.2 Ashfield Engage (Inizio) Business Overview
- 12.5.3 Ashfield Engage (Inizio) Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.5.4 Ashfield Engage (Inizio) Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.5.5 Ashfield Engage (Inizio) Recent Developments
- 12.6 Amplity Health
- 12.6.1 Amplity Health Company Information
- 12.6.2 Amplity Health Business Overview
- 12.6.3 Amplity Health Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.6.4 Amplity Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.6.5 Amplity Health Recent Developments
- 12.7 Sinco Pharma
- 12.7.1 Sinco Pharma Company Information
- 12.7.2 Sinco Pharma Business Overview
- 12.7.3 Sinco Pharma Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.7.4 Sinco Pharma Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.7.5 Sinco Pharma Recent Developments
- 12.8 Syneos Health
- 12.8.1 Syneos Health Company Information
- 12.8.2 Syneos Health Business Overview
- 12.8.3 Syneos Health Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.8.4 Syneos Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.8.5 Syneos Health Recent Developments
- 12.9 EPS Corporation
- 12.9.1 EPS Corporation Company Information
- 12.9.2 EPS Corporation Business Overview
- 12.9.3 EPS Corporation Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.9.4 EPS Corporation Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.9.5 EPS Corporation Recent Developments
- 12.10 Uniphar Group
- 12.10.1 Uniphar Group Company Information
- 12.10.2 Uniphar Group Business Overview
- 12.10.3 Uniphar Group Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.10.4 Uniphar Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.10.5 Uniphar Group Recent Developments
- 12.11 CMIC Group
- 12.11.1 CMIC Group Company Information
- 12.11.2 CMIC Group Business Overview
- 12.11.3 CMIC Group Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.11.4 CMIC Group Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.11.5 CMIC Group Recent Developments
- 12.12 SciClone Pharmaceuticals
- 12.12.1 SciClone Pharmaceuticals Company Information
- 12.12.2 SciClone Pharmaceuticals Business Overview
- 12.12.3 SciClone Pharmaceuticals Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.12.4 SciClone Pharmaceuticals Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.12.5 SciClone Pharmaceuticals Recent Developments
- 12.13 China Pioneer Pharma
- 12.13.1 China Pioneer Pharma Company Information
- 12.13.2 China Pioneer Pharma Business Overview
- 12.13.3 China Pioneer Pharma Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.13.4 China Pioneer Pharma Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.13.5 China Pioneer Pharma Recent Developments
- 12.14 Promoveo Health
- 12.14.1 Promoveo Health Company Information
- 12.14.2 Promoveo Health Business Overview
- 12.14.3 Promoveo Health Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.14.4 Promoveo Health Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.14.5 Promoveo Health Recent Developments
- 12.15 CSO Pharmitalia
- 12.15.1 CSO Pharmitalia Company Information
- 12.15.2 CSO Pharmitalia Business Overview
- 12.15.3 CSO Pharmitalia Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.15.4 CSO Pharmitalia Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.15.5 CSO Pharmitalia Recent Developments
- 12.16 GTS Solution
- 12.16.1 GTS Solution Company Information
- 12.16.2 GTS Solution Business Overview
- 12.16.3 GTS Solution Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.16.4 GTS Solution Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.16.5 GTS Solution Recent Developments
- 12.17 QFR Solutions
- 12.17.1 QFR Solutions Company Information
- 12.17.2 QFR Solutions Business Overview
- 12.17.3 QFR Solutions Revenue in Pharmaceutical Contract Sales Organization (CSO) Business (2021-2026)
- 12.17.4 QFR Solutions Pharmaceutical Contract Sales Organization (CSO) Product Portfolio
- 12.17.5 QFR Solutions Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst